PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives

Radiation Oncology
Sebastian ZschaeckClaus Belka

Abstract

68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PET) is an increasingly used imaging modality in prostate cancer, especially in cases of tumor recurrence after curative intended therapy. Owed to the novelty of the PSMA-targeting tracers, clinical evidence on the value of PSMA-PET is moderate but rapidly increasing. State of the art imaging is pivotal for radiotherapy treatment planning as it may affect dose prescription, target delineation and use of concomitant therapy.This review summarizes the evidence on PSMA-PET imaging from a radiation oncologist's point of view. Additionally a short survey containing twelve examples of patients and 6 additional questions was performed in seven mayor academic centers with experience in PSMA ligand imaging and the findings are reported here.

References

May 1, 1991·International Journal of Radiation Oncology, Biology, Physics·B R RaoC A Perez
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Hellman, R R Weichselbaum
Feb 3, 2005·The Lancet Oncology·Søren M Bentzen
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie T H PeetersJoos V Lebesque
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J StephensonAlan Pollack
Oct 25, 2008·International Journal of Radiation Oncology, Biology, Physics·Colleen A F LawtonMichael Seider
Feb 9, 2012·European Journal of Nuclear Medicine and Molecular Imaging·A Afshar-OromiehC M Zechmann
Jan 22, 2014·Cancer Metastasis Reviews·Lei ChangYong Li
Mar 21, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Matthias EiberMarkus Schwaiger
May 16, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Francesco CeciIrene J Virgolini
Sep 26, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Florian SterzingFrederik L Giesel
Nov 14, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Frederik A VerburgFlorian F Behrendt
Nov 26, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Constantinos ZamboglouAnca-Ligia Grosu
Feb 26, 2016·Clinical Nuclear Medicine·Carl Diedrich SchlenkhoffHojjat Ahmadzadehfar
Mar 15, 2016·European Journal of Nuclear Medicine and Molecular Imaging·F L GieselC Kratochwil
Mar 15, 2016·Clinical Nuclear Medicine·Christina BluemelKen Herrmann
Nov 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wolfgang P FendlerClaudius Faber
Jun 9, 2016·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Christoph HenkenberensThorsten Derlin
Jun 13, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Thomas PykaMatthias Eiber
Aug 17, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rahul D TendulkarAndrew J Stephenson
Aug 26, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Johannes SchwenckChristian la Fougère
Sep 24, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Thomas A HopeMichael J Evans
Dec 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Felix DietleinMarkus Dietlein
May 13, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Ali Afshar-OromiehUwe Haberkorn
May 14, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Constantinos ZamboglouDimos Baltas

❮ Previous
Next ❯

Citations

Jun 15, 2020·Molecular Oncology·Vincent GrégoireDaniel Zips
Aug 21, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mark A GreenJames W Fletcher
Jul 20, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Xiaoxi LingCarolyn J Anderson
Jan 27, 2019·Organic & Biomolecular Chemistry·Phillip T LoweDavid O'Hagan
Sep 12, 2020·Physics in Medicine and Biology·Leticia TaeubertClarissa Gillmann
Mar 23, 2021·Radiation Oncology·Paul RogowskiMinglun Li
Apr 28, 2019·Seminars in Radiation Oncology·Paul KeallJeremy T Booth
Apr 15, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·V IsnardiP Vera
Dec 16, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nina-Sophie Schmidt-HegemannHarun Ilhan
Dec 19, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlJohn Sunderland
Jul 17, 2018·Molecular Pharmaceutics·Alexander WurzerJohannes Notni

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
surgical resection
irradiate

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Anca-Ligia GrosuM Molls
© 2022 Meta ULC. All rights reserved